For example, studies have shown that BCL6 is essential for the survival of GBM cells (Attarha et al., 2017), the overexpression of BCL6 is associated with poor prognosis for glioma patients, BCL6 gene could inhibits the expression of wild-type p53 and its target genes in GBM cells. This evidence concerns the gene BCL6 and central nervous system cancer.